The slip
PARKINSON RECEIPTno. 6150
22 Oct 2026, 06:19 UTCmicroglia, braak
predictionGIMAP4 in microglia tracks Braak Lewy-body stage
registered957eb6fe489d6bed
discovery+0.59 p=0.098 n=9
replication-0.08 p=0.838 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.59, p 0.098)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTca5c91d981af3965bd05f134…
follows ebc7a3e00f4e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6150: GIMAP4 in microglia, braak
- power
- full sample +0.20 (p 0.424, n 18), 95% CI -0.29 to +0.61. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.16 (p 0.532, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.21 (p 0.413, n 18). could be the mix.
- skeptic
- leave-one-out range +0.10 to +0.38, sign flips 0; without severely affected donors +0.20 (p 0.424, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GIMAP4 in microglia.
case closed: nothing better to follow up.